Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Chinese Patent Office
Medtronic
Deloitte
Teva
Merck
UBS
Healthtrust

Generated: July 18, 2018

DrugPatentWatch Database Preview

Protamine sulfate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for protamine sulfate and what is the scope of protamine sulfate freedom to operate?

Protamine sulfate
is the generic ingredient in one branded drug marketed by Fresenius Kabi Usa, Lilly, Pharmacia And Upjohn, and West-ward Pharms Int, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for protamine sulfate. One supplier is listed for this compound.
Summary for protamine sulfate
Pharmacology for protamine sulfate

US Patents and Regulatory Information for protamine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 007413-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 006460-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 007413-002 Aug 2, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 089474-001 Nov 5, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Moodys
Chubb
Harvard Business School
Covington
McKinsey
Cerilliant
Johnson and Johnson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.